Acute Myocardial Infarction
Conditions
Brief summary
The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-CoV2. Investigators have recently studied the complex links between respiratory infections, particularly pneumonia, and type 2 myocardial infarction (MI) in many respects. The etiology of type 2 MI is based on an imbalance of myocardial oxygen supply/need in the absence of rupture/erosion of atheromatous plaques. Based on the RICO survey data, the investigators investigated whether COVID-19-related sepsis and/or respiratory failure could be an underlying mechanism of MI2.
Interventions
BIOLOGICALBiological data
Biological data
OTHERClinical data
Clinical data
Sponsors
Centre Hospitalier Universitaire Dijon
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without pneumonia * patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without COVID 19
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Characterizing type 2 myocardial infarction associated with CoV-2 SARS infection | Through study completion, an average of 1 year |
Countries
France
Outcome results
None listed